Ann: MOU with Temasek-linked Innoventures - Orthopaedics in China, page-22

Depending on shelf life, a pre-emptory purchase on approval? Does China have Special Access Schemes like Australia, where Physicians can use innovative treatments if the present dearth of options in standard of care allow? There is definitely more than one way to skin a cat in China:

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10266112/#:~:text=Results-,Access%20to%20innovative%20medicines,regulations%20implemented%20by%20recent%20reforms.

Just thoughts, I need to do some research on that aspect of Chinese medical access.

https://www.pharmexec.com/view/maximizing-china-access-for-innovative-therapies

I cannot believe this stock is trading here after a Temasek linked deal. Metaphorically looking down the back of the couch as we speak....